🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is done to test how well different types of cancer resp...
Status
Completed
Location
Stanford Cancer Center Palo Alto
Start Date
2015-09-30
Trial ID
NCT02576431
Treatments Being Tested
This is an observational study in which data from the past of children and ...
Status
Completed
Location
Multiple Locations
Start Date
2022-03-10
Trial ID
NCT05236257
Treatments Being Tested
This research study is done to test the safety of the drug larotrectinib in...
Status
Completed
Location
UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center
Start Date
2014-05-04
Trial ID
NCT02122913
Treatments Being Tested
In this observational study researcher want to learn more about the effecti...
Status
Recruiting
Location
Banner Desert Medical Center
Start Date
2020-04-03
Trial ID
NCT04142437
Treatments Being Tested
This is an observational study in which patient data from the past of adult...
Status
Completed
Location
Bayer
Start Date
2021-12-03
Trial ID
NCT05192642
Treatments Being Tested
Larotrectinib expanded access is for patients with cancer with a NTRK1, NTR...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03025360
Treatments Being Tested
The study is being done to test the safety of a cancer drug called larotrec...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles - Hematology/Oncology
Start Date
2015-12-16
Trial ID
NCT02637687
Treatments Being Tested
Researchers want to learn more about the use of larotrectinib as a real-wor...
Status
Recruiting
Location
Many locations
Start Date
2021-11-05
Trial ID
NCT04945330
Treatments Being Tested
This phase II trial studies the effect of larotrectinib in treating patient...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-04-30
Trial ID
NCT04879121
Treatments Being Tested